Dynamic Technology Lab Private Ltd Decreases Position in OraSure Technologies, Inc. (NASDAQ:OSUR)

Dynamic Technology Lab Private Ltd trimmed its holdings in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 54.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 53,233 shares of the medical instruments supplier’s stock after selling 63,144 shares during the quarter. Dynamic Technology Lab Private Ltd owned 0.07% of OraSure Technologies worth $228,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in OSUR. Creative Planning purchased a new position in shares of OraSure Technologies in the third quarter worth $54,000. Mackenzie Financial Corp acquired a new position in shares of OraSure Technologies in the 2nd quarter valued at $72,000. SG Americas Securities LLC lifted its position in OraSure Technologies by 46.4% during the 2nd quarter. SG Americas Securities LLC now owns 17,125 shares of the medical instruments supplier’s stock worth $73,000 after acquiring an additional 5,431 shares during the period. Tidal Investments LLC purchased a new stake in OraSure Technologies during the 1st quarter valued at about $116,000. Finally, Intech Investment Management LLC purchased a new stake in OraSure Technologies during the 3rd quarter valued at about $84,000. 93.50% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently commented on OSUR shares. StockNews.com raised OraSure Technologies from a “hold” rating to a “buy” rating in a report on Friday, October 4th. Evercore ISI upped their price objective on shares of OraSure Technologies from $4.50 to $5.00 and gave the company an “in-line” rating in a report on Wednesday, August 7th.

OraSure Technologies Stock Up 2.6 %

OraSure Technologies stock opened at $3.90 on Tuesday. OraSure Technologies, Inc. has a 52 week low of $3.72 and a 52 week high of $8.45. The firm has a market cap of $290.92 million, a price-to-earnings ratio of 26.00 and a beta of 0.05. The business’s 50-day moving average price is $4.08 and its 200 day moving average price is $4.28.

OraSure Technologies (NASDAQ:OSUR) last posted its earnings results on Wednesday, November 6th. The medical instruments supplier reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.02. OraSure Technologies had a net margin of 5.07% and a return on equity of 3.55%. The firm had revenue of $39.92 million during the quarter, compared to analyst estimates of $38.97 million. During the same period in the previous year, the firm earned $0.27 EPS. The business’s quarterly revenue was down 55.2% on a year-over-year basis. Equities analysts expect that OraSure Technologies, Inc. will post -0.09 EPS for the current year.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.